2020 全球癌症统计报告解读
刘宗超， 李哲轩， 张阳， 周彤， 张婧莹， 游伟程… - 肿瘤综合治疗电子 …, 2021 - jmcm2018.com
2021 年1 月, 国际癌症研究机构团队在美国癌症学会旗下权威杂志《 临床医师癌症杂志》(CA: A
Cancer Journal for Clinicians) 发表了最新的全球癌症统计报告. 该报告阐述了2020 年36 …
Cancer Journal for Clinicians) 发表了最新的全球癌症统计报告. 该报告阐述了2020 年36 …
A comprehensive review of the global efforts on COVID-19 vaccine development
Y Li, R Tenchov, J Smoot, C Liu, S Watkins… - ACS Central …, 2021 - ACS Publications
A Comprehensive Review of the Global Efforts on COVID-19 Vaccine Development | ACS
Central Science ACS ACS Publications C&EN CAS Find my institution Log In ACS Central …
Central Science ACS ACS Publications C&EN CAS Find my institution Log In ACS Central …
COVID-19 and therapy with essential oils having antiviral, anti-inflammatory, and immunomodulatory properties
Abstract Coronavirus disease of 2019 (COVID-19) has emerged as a global health threat.
Unfortunately, there are very limited approved drugs available with established efficacy …
Unfortunately, there are very limited approved drugs available with established efficacy …
[HTML][HTML] Global burden of cancer in 2020 attributable to alcohol consumption: a population-based study
Background Alcohol use is causally linked to multiple cancers. We present global, regional,
and national estimates of alcohol-attributable cancer burden in 2020 to inform alcohol policy …
and national estimates of alcohol-attributable cancer burden in 2020 to inform alcohol policy …
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
This article provides an update on the global cancer burden using the GLOBOCAN 2020
estimates of cancer incidence and mortality produced by the International Agency for …
estimates of cancer incidence and mortality produced by the International Agency for …
[HTML][HTML] Efficacy of glutathione therapy in relieving dyspnea associated with COVID-19 pneumonia: A report of 2 cases
RI Horowitz, PR Freeman, J Bruzzese - Respiratory medicine case reports, 2020 - Elsevier
Purpose Infection with COVID-19 potentially can result in severe outcomes and death from
“cytokine storm syndrome”, resulting in novel coronavirus pneumonia (NCP) with severe …
“cytokine storm syndrome”, resulting in novel coronavirus pneumonia (NCP) with severe …
Drug repositioning: Progress and challenges in drug discovery for various diseases
Y Hua, X Dai, Y Xu, G Xing, H Liu, T Lu, Y Chen… - European Journal of …, 2022 - Elsevier
Compared with traditional de novo drug discovery, drug repurposing has become an
attractive drug discovery strategy due to its low-cost and high efficiency. Through a …
attractive drug discovery strategy due to its low-cost and high efficiency. Through a …
Micronutrients as immunomodulatory tools for COVID-19 management
COVID-19 rapidly turned to a global pandemic posing lethal threats to overwhelming health
care capabilities, despite its relatively low mortality rate. The clinical respiratory symptoms …
care capabilities, despite its relatively low mortality rate. The clinical respiratory symptoms …
Assessing public knowledge, attitudes and determinants of third COVID-19 vaccine booster dose acceptance: current scenario and future perspectives
AA Jairoun, SS Al-Hemyari, F El-Dahiyat… - … of Pharmaceutical Policy …, 2022 - Springer
Background People with weakened immune systems may not develop adequate protection
after taking two doses of the mRNA-combined COVID-19 vaccine. The additional dose may …
after taking two doses of the mRNA-combined COVID-19 vaccine. The additional dose may …
Exploring the Paradox of COVID‐19 in Neurological Complications with Emphasis on Parkinson's and Alzheimer's Disease
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is a human coronavirus
(HCoV) that has created a pandemic situation worldwide as COVID‐19. This virus can …
(HCoV) that has created a pandemic situation worldwide as COVID‐19. This virus can …